Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

sition to continue to execute on our strategies including investments in acquisitions that provide long-term growth for the Company and its shareholders," said Paul Bisaro, President and CEO.  "We saw continued growth in our Global Generics and Global Brands businesses, driven largely by key product launches throughout the year. In 2011, we launched 189 generic products globally, with significant revenue contributions from the U.S. launches of generic versions of Concerta®, Seasonique®, Kadian® and Lipitor®. Investments in our future growth resulted in the filing of 30 new Abbreviated New Drug Applications in the U.S. and more than 130 applications globally."

"In our Global Brands business, we experienced growth from U.S. sales of Rapaflo®, Gelnique® and Crinone®; launched Generess® Fe and Androderm® 2mg, 4mg in the U.S.; and focusing on the long-term future of this business, announced a collaboration with Amgen to develop a portfolio of biosimilar monoclonal antibody (mAb) oncology products," Bisaro continued.

"In 2011, we also continued to utilize our strong balance sheet to expand our global footprint by investing in key growth markets with the expansion of our brand business in Canada and the addition of Specifar Pharmaceuticals to our European operations.  We also realized significant enhancements to our global supply chain through our Operational Excellence framework and announced expansions to our Goa, Malta and Salt Lake City facilities," concluded Bisaro.  Fourth Quarter and Full Year 2011 Business Segment ResultsGlobal Generics Segment InformationThree Months EndedTwelve Months EndedDecember 31,December 31,(Unaudited; $ in millions)

2011201020112010Product sales

$
,161.4$
7.9$
3,320.2$
2,268.9Other revenue

10.938.147.069.5Net revenue

1,172.3646.03,367.22,338.4Operating expenses:Cost of sales

652.0315.31,817.81,198.9Research an
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... June 16, 2011 Reportlinker.com announces that a ... catalogue: US Wound Closure Devices ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Short Description ... market data on the wound closure devices in ...
... 16, 2011 IDenta Corp. (Pink Sheets: IDTA ) ... marketing agreement in Japan with AOYAKA Trading Co. ( ... Mr. Shoham stated, "Japan is a very large and ... is a very tough market, it is not easy to penetrate ...
Cached Medicine Technology:Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2International Drug & Explosives Detection Company IDenta Corp. Announces New Representative in Japan 2
(Date:1/22/2015)... Lynchburg, Va. (PRWEB) January 22, 2015 Liberty ... Health Counseling (M.A.) program from the Council for ... The program, part of Liberty’s Center for Counseling & ... Hawkins, founding dean of the university’s new School of Behavioral ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on Thursday, ... of the Supreme Court decision Roe v. Wade, which legalized abortion ... Roe vs. Wade decision and the fight to protect a women’s ... of West Hollywood Councilmember Abbe Land. “We need to continue to ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering ... follow it on Facebook, Twitter, and Pinterest. The fans will ... draws a lottery every week. , Moreover, the company has ... Click Angelweddingdress homepage for more information. , ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... TUESDAY, Nov. 29 (HealthDay News) -- Among families with ... pay more out of their pockets than those without ... a new study finds. "Even when you are ... covering chronic conditions spent more out of pocket than ...
... of London suggests that many cases of diabetes could be ... study, published today in the British Medical Journal *, ... with reasonable accuracy who will develop diabetes but almost none ... these tools were used by GPs and members of the ...
... HealthDay Reporter , MONDAY, Nov. 28 (HealthDay News) -- Boys ... brains than other children, a new study finds. The ... newborns. However, at age 4 to 6 months, boys who ... have significantly larger heads than other kids, according to the ...
... (DTI) to study the effects of soccer ,heading, researchers have ... have brain abnormalities similar to those found in traumatic brain ... at the annual meeting of the Radiological Society of North ... soccer ball with their head, is an essential part of ...
... Therapeutics, the U.S. subsidiary of the international pharmaceutical group, ... U.S. market, the first and only oral solution medical ... body and found in the brain. Taken for ... or traumatic brain injury (TBI), CerAxon Oral Solution provides ...
... (HealthDay News) --,Women over 50 have more complications -- particularly ... a new study says. The higher rate of complications ... hormone levels, according to the researchers. They looked at ... 2009 and found that the post-surgery infection rate for women ...
Cached Medicine News:Health News:Chronic Disease May Up Out-of-Pocket Costs for Insured 2Health News:Tools for predicting diabetes exist but are not used, research shows 2Health News:Head Size Tied to Regressive Autism in Boys 2Health News:Head Size Tied to Regressive Autism in Boys 3Health News:'Heading' a soccer ball could lead to brain injury 2Health News:Introducing CerAxon Oral Solution 2Health News:Introducing CerAxon Oral Solution 3Health News:Older Women Have More Post-Surgical Breast Reduction Infections 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: